Institutional investors purchased a net $1.9 million shares of ENZ during the quarter ended January 2015, and now own 54.27% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EVERMORE GLOBAL ADVISORS LLC Bought 1.1 Million shares of Enzo Biochem Inc